Literature DB >> 35657082

Changes in Circulating miR-375-3p and Improvements in Visceral and Hepatic Fat Contents in Response to Lifestyle Interventions: The CENTRAL Trial.

Yoriko Heianza1, Knut Krohn2, Anat Yaskolka Meir3,4, Xuan Wang1, Stefanie Ziesche5, Uta Ceglarek6, Matthias Blüher5,7, Maria Keller5,7, Peter Kovacs5, Iris Shai3,8, Lu Qi1,8.   

Abstract

OBJECTIVE: To investigate whether changes in circulating levels of pancreatic islet-related miRNA-375 (miR-375) are related to improved visceral and intrahepatic fat accumulation. RESEARCH DESIGN AND METHODS: This study included adults with abdominal obesity from an 18-month weight loss lifestyle intervention trial. Circulating miR-375-3p was measured at baseline and 18 months. MRI was performed (n = 139) to assess 18-month changes in abdominal and intrahepatic fat depots.
RESULTS: Circulating miR-375-3p was related to fasting insulin and insulin resistance in participants with prediabetes. After the interventions, there was a significant increase of miR-375-3p (P < 0.001). Greater increase in miR-375-3p was associated with greater reductions of visceral (P = 0.024) and deep subcutaneous (P < 0.001) adipose tissues and intrahepatic fat content (P = 0.012).
CONCLUSIONS: Increases in circulating miR-375-3p were associated with visceral and intrahepatic fat reduction. Changes in circulating pancreatic islet-related miR-375-3p may be linked to improved diabetogenic fat depots during weight loss lifestyle interventions.
© 2022 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35657082      PMCID: PMC9346979          DOI: 10.2337/dc21-2517

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   17.152


  15 in total

1.  miR-375 negatively regulates porcine preadipocyte differentiation by targeting BMPR2.

Authors:  Siyuan Liu; Guangjie Sun; Bao Yuan; Lianjiang Zhang; Yan Gao; Hao Jiang; Lisheng Dai; Jiabao Zhang
Journal:  FEBS Lett       Date:  2016-05-12       Impact factor: 4.124

2.  Effect of Distinct Lifestyle Interventions on Mobilization of Fat Storage Pools: CENTRAL Magnetic Resonance Imaging Randomized Controlled Trial.

Authors:  Yftach Gepner; Ilan Shelef; Dan Schwarzfuchs; Hila Zelicha; Lilac Tene; Anat Yaskolka Meir; Gal Tsaban; Noa Cohen; Nitzan Bril; Michal Rein; Dana Serfaty; Shira Kenigsbuch; Oded Komy; Arik Wolak; Yoash Chassidim; Rachel Golan; Hila Avni-Hassid; Avital Bilitzky; Benjamin Sarusi; Eyal Goshen; Elad Shemesh; Yaakov Henkin; Michael Stumvoll; Matthias Blüher; Joachim Thiery; Uta Ceglarek; Assaf Rudich; Meir J Stampfer; Iris Shai
Journal:  Circulation       Date:  2017-11-15       Impact factor: 29.690

3.  Roux-en-Y-Bariatric Surgery Reduces Markers of Metabolic Syndrome in Morbidly Obese Patients.

Authors:  G Rega-Kaun; C Kaun; G Jaegersberger; M Prager; M Hackl; S Demyanets; J Wojta; P J Hohensinner
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

4.  Down-regulation of microRNA-375 regulates adipokines and inhibits inflammatory cytokines by targeting AdipoR2 in non-alcoholic fatty liver disease.

Authors:  Lei Lei; Chao Zhou; Xue Yang; Liangping Li
Journal:  Clin Exp Pharmacol Physiol       Date:  2018-04-30       Impact factor: 2.557

Review 5.  Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement.

Authors:  Ian J Neeland; Robert Ross; Jean-Pierre Després; Yuji Matsuzawa; Shizuya Yamashita; Iris Shai; Jaap Seidell; Paolo Magni; Raul D Santos; Benoit Arsenault; Ada Cuevas; Frank B Hu; Bruce Griffin; Alberto Zambon; Philip Barter; Jean-Charles Fruchart; Robert H Eckel
Journal:  Lancet Diabetes Endocrinol       Date:  2019-07-10       Impact factor: 32.069

6.  Circulating miR-375 as a biomarker of β-cell death and diabetes in mice.

Authors:  Suheda Erener; Majid Mojibian; Jessica K Fox; Heather C Denroche; Timothy J Kieffer
Journal:  Endocrinology       Date:  2013-01-15       Impact factor: 4.736

7.  miR-375 maintains normal pancreatic alpha- and beta-cell mass.

Authors:  Matthew N Poy; Jean Hausser; Mirko Trajkovski; Matthias Braun; Stephan Collins; Patrik Rorsman; Mihaela Zavolan; Markus Stoffel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-16       Impact factor: 11.205

8.  Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis.

Authors:  Carlos J Pirola; Tomas Fernández Gianotti; Gustavo O Castaño; Pablo Mallardi; Julio San Martino; María Mora Gonzalez Lopez Ledesma; Diego Flichman; Faridodin Mirshahi; Arun J Sanyal; Silvia Sookoian
Journal:  Gut       Date:  2014-06-27       Impact factor: 23.059

9.  Acute Weight Loss Restores Dysregulated Circulating MicroRNAs in Individuals Who Are Obese.

Authors:  Patrick Manning; Pujika Emani Munasinghe; Jayanthi Bellae Papannarao; Andrew R Gray; Wayne Sutherland; Rajesh Katare
Journal:  J Clin Endocrinol Metab       Date:  2019-04-01       Impact factor: 5.958

10.  Maternal protein restriction leads to pancreatic failure in offspring: role of misexpressed microRNA-375.

Authors:  Olivier Dumortier; Charlotte Hinault; Nadine Gautier; Stéphanie Patouraux; Virginie Casamento; Emmanuel Van Obberghen
Journal:  Diabetes       Date:  2014-05-16       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.